{"id":"https://openalex.org/W2404173151","doi":null,"title":"Rosiglitazone: an agent from the thiazolidinedione class for the treatment of type 2 diabetes.","display_name":"Rosiglitazone: an agent from the thiazolidinedione class for the treatment of type 2 diabetes.","publication_year":2000,"publication_date":"2000-07-01","ids":{"openalex":"https://openalex.org/W2404173151","mag":"2404173151","pmid":"https://pubmed.ncbi.nlm.nih.gov/11728276"},"language":"en","primary_location":{"id":"pmid:11728276","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11728276","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Heart disease (Hagerstown, Md.)","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002697588","display_name":"Angela Cheng-Lai","orcid":"https://orcid.org/0000-0001-5902-1605","observed_orcids":["https://orcid.org/0000-0001-5902-1605"]},"institutions":[{"id":"https://openalex.org/I1335289525","display_name":"Montefiore Medical Center","ror":"https://ror.org/044ntvm43","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1335289525","https://openalex.org/I19772626"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A Cheng-Lai","raw_affiliation_strings":["Department of Pharmacy Services, Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467, USA. Acheng@Montefiore.org"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Services, Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467, USA. Acheng@Montefiore.org","institution_ids":["https://openalex.org/I1335289525"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061406851","display_name":"Anne Levine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19772626","display_name":"Yeshiva University","ror":"https://ror.org/045x93337","country_code":"US","type":"education","lineage":["https://openalex.org/I19772626"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A Levine","raw_affiliation_strings":["Yeshiva University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yeshiva University","institution_ids":["https://openalex.org/I19772626"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.8415,"has_fulltext":false,"cited_by_count":36,"citation_normalized_percentile":{"value":0.75144619,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"2","issue":"4","first_page":"326","last_page":"33"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9506999850273132,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9506999850273132,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.046799998730421066,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rosiglitazone","display_name":"rosiglitazone","score":1.0},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.9959999918937683},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9919999837875366},{"id":"https://openalex.org/keywords/insulin-sensitivity","display_name":"insulin sensitivity","score":0.7760000228881836},{"id":"https://openalex.org/keywords/ppargamma","display_name":"PPAR\u03b3","score":0.7720000147819519},{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":0.9049999713897705},{"id":"https://openalex.org/keywords/troglitazone","display_name":"troglitazone","score":0.8730000257492065},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7120000123977661},{"id":"https://openalex.org/keywords/edema","display_name":"edema","score":0.7789999842643738},{"id":"https://openalex.org/keywords/heart-failure","display_name":"heart failure","score":0.9200000166893005},{"id":"https://openalex.org/keywords/lipid-profile","display_name":"lipid profile","score":0.574999988079071},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.6309999823570251},{"id":"https://openalex.org/keywords/oral-antidiabetic-drugs","display_name":"oral antidiabetic drugs","score":0.9419999718666077}],"concepts":[{"id":"https://openalex.org/C2780152017","wikidata":"https://www.wikidata.org/wiki/Q424771","display_name":"Rosiglitazone","level":3,"score":0.9872170090675354},{"id":"https://openalex.org/C2776923340","wikidata":"https://www.wikidata.org/wiki/Q1393556","display_name":"Thiazolidinedione","level":4,"score":0.9705241918563843},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9126715660095215},{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.9012496471405029},{"id":"https://openalex.org/C2778150266","wikidata":"https://www.wikidata.org/wiki/Q7844989","display_name":"Troglitazone","level":4,"score":0.8742446899414062},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.73199862241745},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6131874322891235},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5246161222457886},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.48498913645744324},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.44656801223754883},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3879079222679138},{"id":"https://openalex.org/C187345961","wikidata":"https://www.wikidata.org/wiki/Q419629","display_name":"Peroxisome proliferator-activated receptor","level":3,"score":0.1840367317199707},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.10469970107078552}],"mesh":[{"descriptor_ui":"D000077154","descriptor_name":"Rosiglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:11728276","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11728276","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Heart disease (Hagerstown, Md.)","raw_type":"Journal Article"},{"id":"mag:2404173151","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11728276","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2088559970","https://openalex.org/W2001031717","https://openalex.org/W2118502482","https://openalex.org/W2074199206","https://openalex.org/W2179834582","https://openalex.org/W4367481440","https://openalex.org/W6968726195","https://openalex.org/W4232605589","https://openalex.org/W2093013677","https://openalex.org/W2037868476"],"abstract_inverted_index":{"Great":[0],"advances":[1],"have":[2,38,130],"been":[3,131,170,201,226,236],"made":[4],"in":[5,32,85,96,109,124,133,142,159,172,252,260,265],"the":[6,11,26,33,58,71,74,79,86,115,160,215,220,243],"management":[7],"of":[8,18,28,41,52,76,121,136,147,153,164,175,205,245],"diabetes":[9,31,101,129],"during":[10,65,73,180,211,240],"past":[12],"decade.":[13],"Whereas":[14],"only":[15],"one":[16],"class":[17,51],"oral":[19,42],"medications":[20,53],"(the":[21],"sulfonylureas)":[22],"was":[23,54,63,78],"available":[24,158],"for":[25,248],"treatment":[27],"type":[29,99,127],"2":[30,100,128],"early":[34,66],"1990s,":[35],"we":[36],"now":[37],"five":[39],"classes":[40],"antidiabetic":[43],"agents":[44],"from":[45],"which":[46,139],"to":[47,57,82,90,166,193,228,257],"choose.":[48],"The":[49,117],"thiazolidinedione":[50,81,156],"first":[55],"introduced":[56],"United":[59,87,161],"States":[60],"when":[61,188],"troglitazone":[62],"marketed":[64,84],"1997.":[67],"Rosiglitazone,":[68],"approved":[69],"by":[70,102],"FDA":[72],"spring":[75],"1999,":[77],"second":[80],"be":[83,186,229,258],"States.":[88,162],"Similar":[89],"troglitazone,":[91],"rosiglitazone":[92,122,148,179,239],"improves":[93],"insulin":[94],"sensitivity":[95],"patients":[97,125,176,194],"with":[98,126,151,178,195,203,238],"activating":[103],"peroxisome":[104],"proliferator-activated":[105],"receptor-gamma":[106],"(PPARgamma)":[107],"receptors":[108],"adipose":[110],"tissues,":[111],"skeletal":[112],"muscles,":[113],"and":[114,119,208,251,264],"liver.":[116],"efficacy":[118],"safety":[120,244],"therapy":[123],"demonstrated":[132],"a":[134],"number":[135],"clinical":[137,181,212,241,262],"studies,":[138],"are":[140,149],"summarized":[141],"this":[143,189,246],"article.":[144],"Selected":[145],"characteristics":[146],"compared":[150],"those":[152],"pioglitazone--the":[154],"other":[155],"currently":[157],"Edema":[163],"mild":[165],"moderate":[167],"severity":[168],"has":[169,199,224,234],"reported":[171],"approximately":[173],"5%":[174],"treated":[177],"trials.":[182,213],"Therefore,":[183],"caution":[184],"must":[185],"taken":[187],"agent":[190],"is":[191],"administered":[192],"heart":[196],"failure.":[197],"Rosiglitazone":[198],"also":[200],"associated":[202],"elevations":[204],"total,":[206],"LDL,":[207],"HDL":[209],"cholesterol":[210,217,222],"However,":[214],"LDL:HDL":[216],"ratio":[218,223],"or":[219],"total:HDL":[221],"mostly":[225],"observed":[227,237],"unchanged.":[230],"Although":[231],"liver":[232],"toxicity":[233],"not":[235],"trials,":[242],"drug":[247],"long-term":[249],"usage":[250],"larger":[253],"patient":[254],"populations":[255],"remains":[256],"established":[259],"further":[261],"studies":[263],"postmarketing":[266],"experience.":[267]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}